EMILY KENNEY: Open Payments
NPI 1619446069 · LEANDER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 58 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $1,249
Food & beverage: $1,150Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $439 |
| Janssen Biotech, Inc. | 13 | $249 |
| GENZYME CORPORATION | 4 | $143 |
| Madrigal Pharmaceuticals | 5 | $112 |
| Celltrion USA Inc. | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| Aimmune Therapeutics, Inc. | 3 | $54 |
| Gilead Sciences, Inc. | 2 | $34 |
| QOL Medical, LLC | 1 | $19 |
| Biocon Biologics Inc | 1 | $18 |
Products named: TREMFYA, RINVOQ, DUPIXENT, REZDIFFRA, VEGZELMA, LINZESS, XIFAXAN, SKYRIZI.
Industry payments across TX — which companies pay providers there.
